Immunogenic Cell Death in Cancer Therapy

Area of Science:

• Immunology
• Oncology
• Cell Biology

Background:

• Apoptosis is critical for chemotherapy, but recent research suggests it can be immunogenic.
• The concept of immunogenic cell death (ICD) challenges the idea of apoptosis being immunologically silent.

Purpose of the Study:

• To review the key features and molecular mechanisms of ICD induction.
• To discuss the "vaccination effect" of ICD in cancer therapy.
• To classify various ICD inducers and methods.

Main Methods:

• Literature review of studies on immunogenic cell death.
• Analysis of molecular markers associated with ICD.
• Classification of ICD inducers (chemotherapy, proteins, viruses, physical methods).

Main Results:

• ICD involves specific molecular events: surface exposure of calreticulin and HSP70, extracellular release of HMGB1 and ATP.
• Dying cancer cells undergoing ICD can trigger a "vaccination effect," activating antitumor immunity.
• These ICD markers are vital for anticancer therapy effectiveness and basic research.

Conclusions:

• ICD represents a paradigm shift in understanding cell death and cancer therapy.
• ICD induction offers a promising strategy for enhancing antitumor immune responses.
• Further research into ICD mechanisms and inducers can lead to novel cancer treatments.